# Case report: The histopathological analyses of two myelin oligodendrocyte glycoprotein antibody-associated diseases with a distinctive linear radiating gadolinium enhancement on MRI

**Authors:** Mikito Shimizu, Goichi Beck, Shigeo Murayama, Taku Hoshi, Hiroyuki Sumikura, Kyoko Higashida, Isao Fukasaka, Yuki Shimada, Nozomi Nagashima, Tomohiro Fujioka, Naoki Hatayama, Tatsusada Okuno, Hideki Mochizuki, Manabu Sakaguchi

PMC · DOI: 10.3389/fimmu.2024.1426236 · 2024-08-29

## TL;DR

This case report describes two MOGAD patients with unique MRI patterns and brain biopsies showing different levels of axonal damage and brain atrophy.

## Contribution

The study presents the first reported cases of MOGAD with perivascular radial MRI enhancement and highlights axonal involvement as a potential prognostic marker.

## Key findings

- Brain biopsies showed perivenous demyelination and inflammation consistent with ADEM.
- Axonal damage correlated with the severity of cerebral atrophy between the two cases.
- The MRI pattern expands the known radiological spectrum of MOGAD.

## Abstract

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has highly heterogeneous clinical presentations, in which encephalitis is an important phenotype. Moreover, MOGAD has been reported to exhibit diverse imaging findings. However, there have been no previous reports of cases with perivascular radial gadolinium enhancement in periventricular regions, commonly reported in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. In this paper, we present two cases of MOGAD with this MRI feature, both of which underwent brain biopsy for the lesions. Brain biopsies revealed perivenous demyelination and inflammation consistent with acute disseminated encephalomyelitis (ADEM), with pronounced axonal damage in Case 1 and minimal axonal involvement in Case 2. Case 1 exhibited more severe cerebral atrophy than Case 2, correlating with the extent of axonal damage. Through these cases, we highlight the heterogeneity of radiological manifestations of MOGAD, expanding the spectrum beyond previously defined MRI patterns. Furthermore, histopathological analysis revealed distinct axonal involvement as a potential prognostic marker of brain atrophy. These observations emphasize the importance of considering MOGAD in the differential diagnosis, even in cases with atypical imaging findings, and highlight the significance of brain biopsy in guiding both diagnosis and prognosis.

## Linked entities

- **Diseases:** myelin oligodendrocyte glycoprotein antibody-associated disease (MONDO:1040024), encephalitis (MONDO:0019956), acute disseminated encephalomyelitis (MONDO:0019383)

## Full-text entities

- **Genes:** GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, MOG (myelin oligodendrocyte glycoprotein) [NCBI Gene 4340] {aka BTN6, BTNL11, MOGIG2, NRCLP7}
- **Diseases:** brain atrophy (MESH:C566985), inflammation (MESH:D007249), MOGAD (MESH:D003711), axonal damage (MESH:D001480), ADEM (MESH:D004673), encephalitis (MESH:D004660), axonal involvement (MESH:C564676), cerebral atrophy (MESH:D001284)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11390624/full.md

---
Source: https://tomesphere.com/paper/PMC11390624